Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yikang Buyuan is a traditional Chinese medicine (TCM) formulation described as benefiting qi, moving blood, invigorating the spleen, and tonifying the kidney. It is formulated as a tablet and has been studied for its medicinal properties, including inhibition of mouse lymphomata cell EL4 proliferation and modulation of IL-2 activity. The preparation method involves combining specific herbal ingredients according to TCM principles. Its primary indications are related to immune enhancement and possibly cancer adjunct therapy based on preclinical studies[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yikang Buyuan.